InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Ciappenelli Robert D., Directeur Commercial. Officer active across 1 companies, notably Dicerna Pharmaceuticals Inc. Aggregated, 8 disclosures have been published. The latest transaction was filed on 28 December 2021 (U). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€500,08414,813 shares@ €33.759862.1% of flow
Common Stock
SEC:0001399529-21-000196·
€500,08414,813 shares@ €33.759831.1% of flow
Common Stock
SEC:0001399529-21-000196:0·
3,425 shares
Common Stock
SEC:0001399529-21-000177·
3,425 shares
Common Stock
SEC:0001399529-21-000177:0·
€176,7788,856 shares@ €19.961422.0% of flow
Common Stock
SEC:0001399529-21-000164·
€176,7788,856 shares@ €19.961411.0% of flow
Common Stock
SEC:0001399529-21-000164:0·
€128,23910,000 shares@ €12.823915.9% of flow
Common Stock
SEC:0001399529-21-000116·
€128,23910,000 shares@ €12.82398.0% of flow
Common Stock
SEC:0001399529-21-000116:0·
8 of 8 declarations
About Ciappenelli Robert D.
Robert D. Ciappenelli serves as Chief Commercial Officer and Chief Strategy Officer at Dicerna Pharmaceuticals Inc. He is responsible for leading the company's commercial direction and strategy development, contributing to its growth and market position. With expertise in the pharmaceutical sector, he plays a key role in guiding Dicerna's commercial and strategic initiatives.
